P190 BCR-ABL1 Transcript Prevalence in Iranian Children with Acute Lymphoblastic Leukemia
Objectives: Acute lymphoblastic leukemia (ALL) occurs due to the defective maturation of lymphoid cells and lack of differentiation. The present study was aimed to determine the prevalence of P190 BCR-ABL1 transcript in ALL patient and their relation with age, gender, and ethnicity in Iranian population. Methods: This cross-sectional research was done on 50 children with ALL including 28 (56%) males and 22 (44%) females. The presence of P190 BCR-ABL1 transcript was assessed by Nested-PCR technique. Results: From 50 ALL patients, P190 BCR-ABL1 transcript with e1-a2 fusion gene was positive in 2 (4%) cases, one patient (50%) male, and one female (50%) with <5 years old age range and Arab ethnicity. Conclusion: It seems that P190 BCR-ABL1 transcript prevalence and its relations with diagnosis and prognosis, age and ethnicity of ALL patients, need a higher population of the patients to better achievement in this field.
1.Ramanujachar R, Richards S, Hann I, Webb D. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatric blood & cancer. 2006;47:748−56. [CrossRef]
2. Asnafi AA, Khodadi E, Golchin N, Alghasi A, Tavakolifar Y, Saki N. Association between microRNA-21, microRNA-150, and micro-RNA-451 expression and clinical outcome of patients with acute lymphoblastic leukemia. Frontiers in Biology. 2017;12:63−70. [CrossRef]
3. Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27:5175−81. [CrossRef]
4. Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of Tcell leukaemia and lymphoma. Nature Reviews Immunology. 2008;8:380−90. [CrossRef]
5. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lympho-blastic leukemia. Blood. 1998;91:3995−4019.
6. Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 2010;115:206−14.
7. Larson RA. Management of acute lymphoblastic leukemia in older patients. Seminars in hematology. 2006;43:126−33.
8. Aldoss I, Stiller T, Cao TM, Palmer JM, Thomas SH, Forman SJ, et al. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. 2015;21:1326−9. [CrossRef]
9. Wetzler M, Dodge RK, Mrozek K, Stewart CC, Carroll AJ, Tantravahi R, et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. British journal of haematology. 2004;124):275−88. [CrossRef]
10. Jaso J, Thomas DA, Cunningham K, Jorgensen JL, Kantarjian HM, Medeiros LJ, et al. Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors. Cancer. 2011;117:4009−17. [CrossRef]
11. Morel F, Herry A, Le Bris MJ, Morice P, Bouquard P, Abgrall JF, et al. Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer genetics and cytogenetics. 2003;147:115−20. [CrossRef]
12. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer research. 1995;55:34−8.
13. Soler G, Radford-Weiss I, Ben-Abdelali R, Mahlaoui N, Ponceau JF, Macintyre EA, et al. Fusion of ZMIZ1 to ABL1 in a Bcell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation. Leukemia. 2008;22:1278−80. [CrossRef]
14. Lee J, Beliakoff J, Sun Z. The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic acids research. 2007;35:4523−34. [CrossRef]
15. De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood. 2005;105:4849−52. [CrossRef]
16. De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Berthou C, Morel F, De Braekeleer M. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia. Leukemia. 2007;21:2220−1. [CrossRef]
17. Mustjoki S, Hernesniemi S, Rauhala A, Kahkonen M, Almqvist A, Lundan T, et al. A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34). Haematologica. 2009;94:1469−71. [CrossRef]
18. Gheisari Z, Beiranvand R, Karimi A, Ghalavandi S, Soleymani A, Madmoli M, Bavarsad AH. Relationship between Occupational Stress and Cardiovascular Risk Factors Determination: A Case-control Study. Journal of Research in Medical and Dental Science. 2018; 6:287−93.
19. Hidalgo-Curtis C, Chase A, Drachenberg M, Roberts MW, Finkelstein JZ, Mould S, et al. The t(1;9)(p34;q34) and t(8;12) (p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes, chromosomes & cancer. 2008;47:379−85. [CrossRef]
20. Shav-Tal Y, Zipori D. PSF and p54(nrb)/NonO--multi-functional nuclear proteins. FEBS letters. 2002;531:109−14. [CrossRef]
21. Wang JY. Abl tyrosine kinase in signal transduction and cellcycle regulation. Current opinion in genetics & development. 1993;3:35−43. [CrossRef]
22. Colicelli J. ABL tyrosine kinases: evolution of function, regula-tion, and specificity. Science Signaling. 2010;3:re6. [CrossRef]
23. Faiz M, Iqbal QJ, Qureshi A. High prevalence of BCR-ABL fusion transcripts with poor prognostic impact among adult ALL patients: report from Pakistan. Asia-Pacific journal of clinical oncology. 2011;7:47−55. [CrossRef]
24. Gutierrez MI, Timson G, Siraj AK, Bu R, Barbhaya S, Banavali S, et al. Single monochrome real-time RT-PCR assay for identification, quantification, and breakpoint cluster region determination of t(9;22) transcripts. The Journal of molecular diagnostics: JMD. 2005;7:40−7. [CrossRef]
25. Gleissner B, Gokbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW, et al. Leading prognostic relevance of the BCRABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood. 2002;99:1536−43. [CrossRef]